In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 46.2 | 46.6 | 38.0 | 32.5 | 31.6 | 32.0 | 33.2 | 37.6 |
Interest income on investments | 1.6 | 1.9 | 2.1 | 3.2 | 4.6 | 6.1 | 6.1 | 4.5 |
| 47.9 | 48.6 | 40.2 | 36.4 | 37.2 | 38.6 | 39.4 | 42.6 |
Interest on deposits | 3.9 | 4.5 | 4.1 | 4.4 | 5.8 | 6.6 | 8.8 | 12.9 |
Total interest expense | 6.9 | 6.8 | 6.5 | 7.4 | 8.7 | 9.7 | 12.1 | 16.7 |
Net interest income | 41.3 | 41.9 | 33.8 | 29.0 | 28.5 | 28.9 | 27.3 | 114.3 |
Provision for loan losses | 1.1 | 0.9 | 1.0 | 2.7 | 1.4 | 2.2 | 6.0 | 1.1 |
Net interest income after provision for loan losses | 40.2 | 41.0 | 32.8 | 26.3 | 27.1 | 26.7 | 21.4 | 113.2 |
Deposit and loan fees | 5.8 | 6.0 | 5.2 | 5.1 | 5.1 | 5.2 | 5.4 | |
Gain on sale of investments, net | 0.3 | 1.0 | 1.0 | 3.8 | 2.6 | 2.1 | 3.6 | |
Other non-interest income | 12.5 | 12.3 | 9.5 | 5.7 | 2.8 | 3.0 | 3.8 | 7.7 |
Total non-interest income | 18.6 | 19.2 | 15.7 | 14.6 | 10.5 | 10.3 | 12.8 | 7.7 |
Non-interest expenses | 46.2 | 46.6 | 37.0 | 29.4 | 27.1 | 25.5 | 24.5 | 24.6 |
Equity in earnings | -1.3 | 7.0 | 6.0 | 9.6 | 8.8 | 0.7 | 0.1 | |
Pre-tax income | 12.6 | 13.6 | 11.5 | 11.4 | 10.5 | 11.5 | 9.7 | 7.9 |
Income taxes | 3.6 | 3.6 | 3.1 | 3.7 | 2.8 | 3.5 | 3.1 | 2.2 |
Tax rate | 28.5% | 26.2% | 27.1% | 32.2% | 26.8% | 30.8% | 32.1% | 27.5% |
Net income | 8.9 | 9.8 | 8.1 | 7.1 | 7.0 | 7.4 | 6.1 | 5.7 |
Net margin | 15.1% | 16.3% | 16.7% | 17.4% | 18.5% | 20.1% | 17.8% | 4.7% |
|
Basic EPS | $1.08 | $1.19 | $1.11 | $1.20 | $1.20 | $1.29 | $1.06 | $1.00 |
Diluted EPS | $1.08 | $1.19 | $1.11 | $1.20 | $1.20 | $1.29 | $1.06 | $1.00 |
|
Shares outstanding (basic) | 8.2 | 8.2 | 7.3 | 5.9 | 5.8 | 5.8 | 5.8 | 5.7 |
Shares outstanding (diluted) | 8.3 | 8.2 | 7.3 | 5.9 | 5.8 | 5.8 | 5.8 | 5.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |